|
"ann lii cheng"的相關文件
顯示項目 621-645 / 690 (共28頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T08:15:22Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao, Y.-Y. and Kuo, K.-T. and Hu, F.-C. and Lu, Y.-S. and Huang, C.-S. and Liau, J.-Y. and Lee, W.-C. and Hsu, C. and Kuo, W.-H. and Chang, K.-J. and Lin, C.-H. and Cheng, A.-L.; CHIUN-SHENG HUANG; Yu-Yun Shao; JAU-YU LIAU; CHING-HUNG LIN; KUAN-TING KUO; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:48Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata, M.;Lesmana, L.A.;Tateishi, R.;Chen, P.-J.;Lin, S.-M.;Yoshida, H.;Kudo, M.;Lee, J.M.;Choi, B.I.;Poon, R.T.P.;Shiina, S.;Cheng, A.L.;Jia, J.-D.;Obi, S.;Han, K.H.;Jafri, W.;Chow, P.;Lim, S.G.;Chawla, Y.K.;Budihusodo, U.;Gani, R.A.;Lesmana, C.R.;Putranto, T.A.;Liaw, Y.F.;Sarin, S.K.; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
|
Chen, K.-F.;Yu, H.-C.;Liu, T.-H.;Lee, S.-S.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG; SHOEI-SHENG LEE |
| 臺大學術典藏 |
2018-09-10T08:06:38Z |
Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, S.-H. and Yen, R.-F. and Lin, C.-W. and Chen, L.-T. and Tien, H.F. and Cheng, A.-L.; HWEI-FANG TIEN; Sung-Hsin Kuo; RUOH-FANG YEN; CHUNG-WU LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:37Z |
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells
|
Weng, Y.-I.;Hsu, P.-Y.;Liyanarachchi, S.;Liu, J.;Deatherage, D.E.;Huang, Y.-W.;Zuo, T.;Rodriguez, B.;Lin, C.-H.;Cheng, A.-L.;Huang, T.H.-M.; CHING-HUNG LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:36Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu, Pei-Fang;Kuo, Kuan-Ting;Kuo, Lu-Ting;Lin, Yi-Ting;Lee, Wei-Chung;Lu, Yen-Shen;Yang, Chih-Hsin;Wu, Ruey-Meei;Tu, Yong-Kwang;Tasi, Jui-Chang;Tseng, Ham-Min;Tseng, Sheng-Hong;Cheng, Ann-Lii;Lin, Ching-Hung; Wu, Pei-Fang; Ruey-Meei Wu; Lu-Ting Kuo; Kuo, Kuan-Ting; Kuo, Lu-Ting; Yong-Kwang Tu; Lin, Yi-Ting; CHING-HUNG LIN; KUAN-TING KUO; Lee, Wei-Chung; ANN-LII CHENG; Lu, Yen-Shen; Yang, Chih-Hsin; Wu, Ruey-Meei; Tu, Yong-Kwang; Tasi, Jui-Chang; Tseng, Ham-Min; Tseng, Sheng-Hong; Cheng, Ann-Lii; Lin, Ching-Hung |
| 臺大學術典藏 |
2018-09-10T08:04:03Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:03:10Z |
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
|
Lin, Z.-Z. and Jeng, Y.-M. and Hu, F.-C. and Pan, H.-W. and Tsao, H.-W. and Lai, P. and Lee, P. and Cheng, A.-L. and Hsu, H.-C.; PO-HUANG LEE; YUNG-MING JENG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway
|
Chou, C.H. and Chen, P.-J. and Jeng, Y.-M. and Cheng, A.-L. and Huang, L.-R. and Cheng, J.C.-H.; YUNG-MING JENG; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:26:16Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang, H.-J. and Huang, C.-L. and Wang, H.-P. and Shiah, H.-S. and Chang, M.-C. and Jan, C.-M. and Chen, J.-S. and Tien, Y.-W. and Hwang, T.-L. and Lin, J.-T. and Cheng, A.-L. and Whang-Peng, J. and Chen, L.-T.; YU-WEN TIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:25:03Z |
Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma
|
Yeh, K.-H.;Lien, H.-C.;Hsu, S.-M.;Cheng, A.-L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:25:02Z |
Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast – a review of 42 primary and secondary cases in Taiwanese patients
|
Yu-Chin Lin and Chung-Hsin Tsai and Jia-Shing Wu and Chiun-Sheng Huang and Sung-Hsin Kuo and Chung-Wu Lin and Ann-Lii Cheng; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHUNG-WU LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:25:02Z |
Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application
|
Lee, J.-H. and Cheng, A.-L. and Lin, C.-W. and Kuo, S.-H.; 鄭安理;林中梧;郭頌鑫; CHENG, ANN-LII;LIN, CHUNG-WU;KUO, SUNG- HSIN; Sung-Hsin Kuo; CHUNG-WU LIN; ANN-LII CHENG; CHENG, ANN-LII; LIN, CHUNG-WU; KUO, SUNG- HSIN; 林麗嬋; 王亭貴; 陳妙言; 吳肖琪 |
| 臺大學術典藏 |
2018-09-10T07:25:01Z |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma
|
Zhong-Zhe Lin and Hey-Chi Hsu and Chih-Hung Hsu and Pei-Yen Yeh and Chi-Ying F. Huang and Yung-Feng Huang and Te-Jung Chen and Sung-Hsin Kuo and Chiun Hsu and Fu-Chang Hu and Yung-Ming Jeng and Ying Chung and Ann-Lii Cheng; YUNG-MING JENG; CHIH-HUNG HSU; Sung-Hsin Kuo; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:23:51Z |
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients
|
Chen, C.-H. and Hu, F.-C. and Huang, G.-T. and Lee, P.-H. and Tsang, Y.-M. and Cheng, A.-L. and Chen, D.-S. and Wang, J.-D. and Sheu, J.-C.; PO-HUANG LEE; JIN-CHUAN SHEU; GUAN-TARN HUANG; DING-SHINN CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:22:33Z |
Hypermethylation of the p16 gene in sporadic T3NOMO stage colorectal cancers: Association with DNA replication error and shorter survival
|
Liang, J.-T.;Chang, K.-J.;Chen, J.-C.;Lee, C.-C.;Cheng, Y.-M.;Hsu, H.-C.;Wu, M.-S.;Wang, S.-M.;Lin, J.-T.;Cheng, A.-L.; Jin-Tung Liang; MING-SHIANG WU; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:20:11Z |
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma
|
Yang, C.-H.;Cheng, A.-L.;Yeh, K.-H.;Yu, C.-J.;Lin, J.-F.;Yang, P.-C.; Chong-Jen Yu; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:20:08Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
Huang, C.-L.;Yang, C.-H.;Yeh, K.-H.;Hu, F.-C.;Chen, K.-Y.;Shih, J.-Y.;Lin, Z.-Z.;Yu, C.-J.;Cheng, A.-L.;Yang, P.-C.; Chong-Jen Yu; KUN-HUEI YEH; JIN-YUAN SHIH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:19:44Z |
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival
|
Shen, Y.-C. and Hu, F.-C. and Jeng, Y.-M. and Chang, Y.-T. and Lin, Z.-Z. and Chang, M.-C. and Hsu, C. and Cheng, A.-L.; 沈盈君;胡賦強;鄭永銘;張毓廷;林宗哲;章明珠;許駿;鄭安理; SHEN, YING-CHUN;HU, FU-CHANG;JENG, YUNG-MING;CHANG, YU-TING;LIN, ZONG-ZHE;CHANG, MING-CHU;HSU, CHIUN;CHENG, ANN-LII; YUNG-MING JENG; YU-TING CHANG; ANN-LII CHENG; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG-MING; CHANG, YU-TING; LIN, ZONG-ZHE; CHANG, MING-CHU; HSU, CHIUN; CHENG, ANN-LII |
| 臺大學術典藏 |
2018-09-10T07:10:15Z |
Organization-based performance measures of cancer care quality: Core measure development for breast cancer in Taiwan
|
Chung, K.-P.;Lai, M.-S.;Cheng, S.H.;Tang, S.-T.;Huang, C.C.;Cheng, A.-L.;Hsieh, P.-C.; Chung, KP; CHUNG, K.-P.; KUO-PIAO CHUNG; LAI, M.-S.; ANN-LII CHENG; Lai, MS; CHENG, S.H.; Cheng, SH; TANG, S.-T.; Tang, SS; Tang, ST; Huang, CC; Huang, CC; HUANG, C.C.; Cheng, AL; Cheng, AL; CHENG, A.-L.; Hsieh, PC; HSIEH, P.-C.; Hsieh, PC |
| 臺大學術典藏 |
2018-09-10T06:55:45Z |
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system
|
Lien, HC;Lu, YS;Shun, CT;Yao, YT;Chang, WC;Cheng, AL; Lien, H.-C. and Lu, Y.-S. and Shun, C.-T. and Yao, Y.-T. and Chang, W.-C. and Cheng, A.-L.; Lien, HC; CHIA-TUNG SHUN; HUANG-CHUN LIEN; Lu, YS; ANN-LII CHENG; Shun, CT; Yao, YT; Chang, WC; Cheng, AL |
| 臺大學術典藏 |
2018-09-10T06:53:03Z |
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: A pilot study of the BOMES protocol
|
Cheng, A.-L. and Yeh, K.-H. and Uen, W.-C. and Hung, R.-L. and Liu, M.-Y. and Wang, C.-H.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:53:00Z |
Comprehensive Locoregional Treatment and Systemic Therapy for Postmastectomy Isolated Locoregional Recurrence
|
Sung-Hsin Kuo and Chiun-Sheng Huang and Wun-Hon Kuo and Ann-Lii Cheng and King-Jeng Chang and Jason Chia-Hsien Cheng; CHIUN-SHENG HUANG; Sung-Hsin Kuo; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:52:59Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial
|
Chiun Hsu and Sung-Hsin Kuo and Fu-Chang Hu and Ann-Lii Cheng and Jin-Yuan Shih and Chong-Jen Yu and Chia-Chi Lin and Tsu-Chen Huang and Pan-Chyr Yang and Chih-Hsin Yang; Chong-Jen Yu; Sung-Hsin Kuo; JIN-YUAN SHIH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:52:55Z |
Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells
|
Lin, H.-J.L.;Zuo, T.;Lin, C.-H.;Chieh, T.K.;Liyanarachchi, S.;Sun, S.;Shen, R.;Deatherage, D.E.;Potter, D.;Asamoto, L.;Lin, S.;Yan, P.S.;Cheng, A.-L.;Ostrowski, M.C.;Huang, T.H.-M.; CHING-HUNG LIN; ANN-LII CHENG |
顯示項目 621-645 / 690 (共28頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目
|
